Atrial, SA nodal, and AV nodal electrophysiology in standing horses: Normal findings and electrophysiologic effects of quinidine and diltiazem

Journal of Veterinary Internal Medicine

Volumn 21, Issue 1, 2007, Pages 166-175

  Schwarzwald, Colin C ^a   Hamlin, Robert L ^a,b   Bonagura, John D ^a   Nishijima, Yoshinori ^a   Meadows, Cheyney ^a   Carnes, Cynthia A ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Atrial fibrillation; Cardiology; Drug effects; Equine; Programmed electrical stimulation

Indexed keywords

CARDIOVASCULAR AGENT; DILTIAZEM; QUINIDINE;

ANIMAL; ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFECT; FEMALE; HEART ATRIOVENTRICULAR NODE; HEART ATRIUM; HEART ATRIUM FUNCTION; HEART FUNCTION TEST; HORSE; MALE; PHYSIOLOGY; SINUS NODE;

ANIMALS; ATRIAL FUNCTION; ATRIOVENTRICULAR NODE; CARDIOVASCULAR AGENTS; DILTIAZEM; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; FEMALE; HEART ATRIA; HORSES; MALE; QUINIDINE; SINOATRIAL NODE;

ANIMALIA; EQUIDAE;

EID: 33847012195     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1892/0891-6640(2007)21[166:ASNAAN]2.0.CO;2     Document Type: Article

References (41)

1. Trikas AG, Tentolouris KA, Tousoulis D, et al. Left atrial function under exercise. Eur Heart J Suppl 2000;2:K34-K37.
2. Reef VB, Reimer JM, Spencer PA. Treatment of atrial fibrillation in horses: New perspectives. J Vet Int Med 1995;9:57-67.
3. Collatos C. Update on equine therapeutics - treating atrialfibrillation in horses. Compend Contin Educ Pract Vet 1995;17:243-245.
4. Cooke KL, Snyder PS. Calcium channel blockers in veterinary medicine. J Vet Intern Med 1998;12:123-131.
5. Abernethy DR, Schwartz JB. Calcium-antagonist drugs. N Engl J Med 1999;341:1447-1457.
6. Opie LH, Gersh BJ. Drugs for the Heart, 6th ed. Philadelphia: WB Saunders; 2005.
7. Schwarzwald CC, Bonagura JD, Luis-Fuentes V. Effects of diltiazem on hemodynamic variables and ventricular function in healthy horses. J Vet Int Med 2005;19:703-711.
8. Opie LH. Calcium channel blockers (calcium antagonists). In: Opie LH, Gersh BJ, eds. Drugs for the Heart, 5th ed. Philadelphia: WB Saunders; 2001:53-83.
9. Camm AJ, Al-Saady NM, Opie LH. Antiarrhythmic agents. In: Opie LH, Gersh BJ, eds. Drugs for the Heart, 5th ed. Philadelphia: WB Saunders; 2001:221-272.
10. Moïse NS. Diagnosis and management of canine arrhythmias. In: Fox PR, Sisson D, Moïse NS, eds. Textbook of Canine and Feline Cardiology, 2nd ed. Philadelphia: WB Saunders; 1999:331-385.
11. Talajic M, Nattel S. Frequency-dependent effects of calcium antagonists on atrioventricular conduction and refractoriness: Demonstration and characterization in anesthetized dogs. Circulation 1986;74:1156-1167.
12. Talajic M, Lemery R, Roy D, et al. Rate-dependent effects of diltiazem on human atrioventricular nodal properties. Circulation 1992;86:870-877.
13. Pool PE. Diltiazem. In: Messerli FH, ed. Cardiovascular Drug Therapy, 2nd ed. Philadelphia: WB Saunders; 1996:931-971.
14. Tavernor WD. Technique for the subcutaneous relocation of the common carotid artery in the horse. Am J Vet Res 1969;30:1881-1884.
15. Fogoros RN. Electrophysiologic testing, 3rd ed. Oxford: Blackwell Science; 1999:280.
16. Yamaya Y, Kubo K, Amada A, et al. Intrinsic atrioventricular conductive function in horses with a second degree atrioventricular block. J Vet Med Sci 1997;59:149-151.
17. Davey P. How to correct the QT interval for the effects of heart rate in clinical studies. J Pharmacol Toxicol Methods 2002;48:3-9.
18. Van Loon G, Duytschaever M, Tavernier R, et al. An equine model of chronic atrial fibrillation: Methodology. Vet J 2002;164:142-150.
19. Vlay SC. Electrophysiologic testing. In: Vlay SC, ed. A practical approach to cardiac arrhythmias, 2nd ed. Boston: Little, Brown and Company; 1995:228-279.
20. Morillo CA, Klein GJ, Jones DL, et al. Chronic rapid atrial pacing. Structural, functional, and electrophysiological character istics of a new model of sustained atrial fibrillation. Circulation 1995;91:1588-1595.
21. Billette J, Nadeau R A, Roberge F. Relation between the minimum RR interval during atrial fibrillation and the functional refractory period of the AV junction. Cardiovasc Res 1974;8:347-351.
22. Muir WW. Treatment of atrial fibrillation in horses by intravenous administration of quinidine. J Am Vet Med Assoc 1990;197:1607-1610.
23. McGuirk SM, Muir WW, Sams RA. Pharmacokinetic analysis of intravenously and orally administered quinidine in horses. Am J Vet Res 1981;42:938-942.
24. Clozel JP, Caille G, Taeymans Y, et al. Improved gas Chromatographic determination of diltiazem and deacetyldiltiazem in human plasma. J Pharm Sci 1984;73:207-209.
25. Katz AM. The cardiac action potential. In: Katz AM, ed. Physiology of the Heart, 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2001:478-516.
26. Roden DM. Cardiac membrane and action potentials. In: Spooner PM, Rosen MR, eds. Foundation of Cardiac Arrhythmias: Basic Concepts And Clinical Approaches. New York: Marcel Dekker, Inc. 2001:21-41.
27. Wijffels MC, Kirchhof CJ, Dorland R, et al. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 1995;92:1954-1968.
28. Goette A, Honeycutt C, Langberg JJ. Electrical remodeling in atrial fibrillation. Time course and mechanisms. Circulation 1996;94:2968-2974.
29. Daoud EG, Bogun F, Goyal R, et al. Effect of atrial fibrillation on atrial refractoriness in humans. Circulation 1996;94:1600-1606.
30. Allessie M, Ausma J, Schotten U. Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Res 2002;54:230-246.
31. Franz MR, Karasik PL, Li C, et al. Electrical remodeling of the human atrium: Similar effects in patients with chronic atrial fibrillation and atrial flutter. J Am Coll Cardiol 1997;30:1785-1792.
32. Yu WC, Lee SH, Tai CT, et al. Reversal of atrial electrical remodeling following cardioversion of longstanding atrial fibrillation in man. Cardiovasc Res 1999;42:470-476.
33. Yamaya Y, Kubo K, Amada A. Relationship between atrio-ventricular conduction and hemodynamics during atrial pacing in horses. J Equine Sci 1997;8:35-38.
34. Gelzer ARM, Moïse NS, Vaidya D, et al. Temporal organization of atrial activity and irregular ventricular rhythm during spontaneous atrial fibrillation: An in vivo study in the horse. J Cardiovasc Electrophysiol 2000;11:773-784.
35. Dias VC, Weir SJ, Ellenbogen KA. Pharmacokinetics and pharmacodynamics of intravenous diltiazem in patients with atrial fibrillation or atrial flutter. Circulation 1992;86:1421-1428.
36. Miyamoto M, Nishijima Y, Nakayama T, et al. Cardiovascular effects of intravenous diltiazem in dogs with iatrogenic atrial fibrillation. J Vet Intern Med 2000;14:445-451.
37. Boucher M, Dubray C, Duchene-Marullaz P. Effects of bepridil, diltiazem and verapamil on atrial refractoriness and heart rate in the conscious dog: Comparison with quinidine. Gen Pharmacol 1991;22:581-587.
38. Shenasa M, Kus T, Fromer M, et al. Effect of intravenous and oral calcium antagonists (diltiazem and verapamil) on sustenance of atrial fibrillation. Am J Cardiol 1988;62:403-407.
39. Lee SH, Yu WC, Cheng JJ, et al. Effect of verapamil on long-term tachycardia-induced atrial electrical remodeling. Circulation 2000;101:200-206.
40. Ramanna H, Elvan A, Wittkampf FH, et al. Increased dispersion and shortened refractoriness caused by verapamil in chronic atrial fibrillation. J Am Coll Cardiol 2001;37:1403-1407.
41. Nappi JM, Mason JW. Quinidine. In: Messerli FH, ed. Cardiovascular Drug Therapy, 2nd ed. Philadelphia: WB Saunders; 1996:1362-1369.